NovoMedix, LLC
PrivateLast Round
Grant
Mar 25, 2026
Total Funding Raised
$5.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NovoMedix, LLC is a biotechnology company that develops novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoMedix, LLC Comparables
Compare NovoMedix, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lassen Therapeutics | 66% | |
| Mediar Therapeutics | 58% | |
| Pliant Therapeutics | 56% |
NovoMedix, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 25, 2026 | ||||
| Grant | May 26, 2022 |
NovoMedix, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- Jul 26, 2026
Monthly visitors increased 72% MoM.
NovoMedix, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access